CLOs on the Move

IML Worldwide

www.imlworldwide.com

 
IML Worldwide is a New York, NY-based company in the Business Services sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Michael Gardner Inc

Michael Gardner Inc is a Calcium, NY-based company in the Business Services sector.

Relay

Relay is a cloud-based communications technology company that focuses on enhancing workplace safety, productivity, and operational efficiency for frontline teams. It offers a unified communication platform tailored for industries such as hospitality, healthcare, and logistics. Relays solutions include smart radio hardware for real-time voice communication, a cloud software platform for device management and data analysis, and mobile connectivity with nationwide LTE/5G support. The company emphasizes seamless communication across devices and locations, featuring safety tools like emergency alerts and real-time location tracking. Relay also provides performance analytics to help optimize team workflows. With a commitment to customer support, Relay offers dedicated success teams, live troubleshooting, and a variety of resources for onboarding and training. The company has received positive feedback from clients and has achieved significant milestones, including delivering over 2.5 billion messages and mapping over 1 million locations.

Armstrong Tech Inc

Armstrong Tech Inc is a Auburn, CA-based company in the Business Services sector.

Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.

Millarch Corporation

Millarch Corporation is a Saint-Jí©ríÇme, QC-based company in the Business Services sector.